Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Pfizer has fully exited its investment in UK-listed pharma group Haleon, selling off its remaining 7.3% stake for £2.5bn.

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have received a consensus rating of “Moderate Buy” from the seventeen ...

Pfizer divested 7.3% remaining stake in Haleon, or approximately 662 million shares, to institutional investors and Haleon ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...

March 18 (Reuters) - Pfizer (PFE.N), opens new tab will sell its remaining stake in British consumer healthcare group Haleon (HLN.L), opens new tab, the companies said on Tuesday. Pfizer will sell ...

Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, ...

The Health and Human Services Department is weighing plans to “drastically” cut the federal government’s funding for domestic HIV prevention, ...

Santander is to shut almost a quarter of its branch network in June, putting 750 jobs at risk. The Spanish owned high street ...